Cheap on enterprise value stocks: what the screen found on November 21, 2026
Only 40 companies passed this screen out of 1,163 that had the necessary data available on October 8, 2026. The most extreme figure is The Chemours Company (CC), which shows an EV/EBITDA of 0.43.
Key figures
Data as of Nov 21, 2026- CC (The Chemours Company) market cap
- $2.07B
- PRU (Prudential Financial, Inc.) market cap
- $39.10B
- BBT (Beacon Financial Corporation) market cap
- $2.30B
- DXC (DXC Technology Company) market cap
- $1.98B
- BOW (Bowhead Specialty Holdings Inc.) market cap
- $1.12B
- TRN (Trinity Industries, Inc.) market cap
- $2.02B
Only 40 companies¹ passed this screen out of 1,163² that had the necessary data available on October 8, 2026. The most extreme figure is The Chemours Company (CC), which shows an EV/EBITDA of 0.43³.
This specific test identifies companies with a low EV/EBITDA. Because this metric includes debt, it is not flattered by a leveraged balance sheet in the way a P/E ratio might be. However, passing this test does not establish that a company is worth owning; it is a numerical filter, not a verdict on a stock's quality or future.
The matches range from an EV/EBITDA of 0.43 to 5.8⁴, with a median of 4.43⁵. Beyond The Chemours Company—a manufacturing firm with a $2.07B market cap⁶—other low-multiple names include Prudential Financial ($39.10B market cap, 1.53 EV/EBITDA⁷˒⁸) and Beacon Financial Corporation ($2.30B market cap, 1.88 EV/EBITDA⁹˒¹⁰). Both operate in the Finance, Insurance & Real Estate sector. Other passing companies include DXC Technology Company in the services sector with a 2.19 EV/EBITDA¹¹ and Trinity Industries in manufacturing with a 2.67 EV/EBITDA¹².
Recent records show a class action announcement for Chemours and a dividend for Prudential Financial on November 24. Executive or board changes were reported in recent 8-K filings for Chemours, Beacon Financial, and Bowhead Specialty Holdings.
Educational tool. Not investment advice. This article was produced with automated assistance. Every figure in it was checked against the underlying data before it was published; the interpretation was not.